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tein databases. This search resulted in the identification of one novel 
peptide spanning aa 83-95 of rhodanese-related sulfurtransferase in 
Acanthamoeba castellanii (ACA) and it induces EAE similar to that of 
PLP 139-151.
2. Materials and methods
2.1. Mice
Four to six-week-old female SJL/J (H-2s) mice were obtained from 
the Jackson Laboratory (Bar Harbor, Maine). The mice were main-
tained in accordance with the animal protocol guidelines of the Uni-
versity of Nebraska-Lincoln, Lincoln, Nebraska.
2.2. Peptide synthesis and immunization procedures
PLP 139-151 (HSLGKWLGHPDKF), ACA 83-95 (YFLLKWLGH-
PNVS) and neuraminidase (NASE) 101-120 (EALVRQGLAKVAY-
VYKPNNT) were synthesized on 9-fluorenylmethyloxycarbonyl 
chemistry (Neopeptide, Cambridge, Massachusetts). All peptides 
were HPLC-purified (N90%) and confirmed by mass spectroscopy. 
To measure recall responses 100 µg of each peptide emulsified in 
CFA was administered subcutaneously in the flank. For disease 
induction, Mycobacterium tuberculosis (MTB) H37RA extract (Difco 
Laboratories, Detroit, Michigan) was added as an additional compo-
nent to a final concentration of 5 mg/ml. Pertussis toxin (List Biolog-
ical Laboratories, Campbell, California) was administered (100 ng 
per mouse) intraperitoneally on day 0 and day 2 postimmunization.
2.3. Identification of microbial peptides that mimic PLP 139-151
PLP 139-151 is an immunodominant epitope in which the critical 
residues required for major histocompatibility complex (MHC) class 
II and T cell receptor (TCR)-binding have been well-characterized 
(Figure 1). By using PLP 139-151 as a putative antigen, we performed 
pattern search using the prosite scan of the Bioinformatics Toolkit 
(http://toolkit.tuebingen.mpg.de/patsearch, Max-Planck Institute 
for Developmental Biology, Tubingen, Germany). The pattern that 
we used was XXLXXWLXHPXXX (underlined: TCR-contact resi-
dues; bold: MHC-anchor residues; X: non-critical residues).
2.4. Clinical scoring and histopathology
Following EAE induction, the mice were monitored for clinical 
signs of disease and scored as described previously (Tuohy et al., 
1989): 0, healthy; 1, limp tail or hind limb weakness, but not both; 2, 
limp tail and hind limb weakness; 3, partial paralysis of hind limbs; 
4, complete paralysis of hind limbs; 5, moribund or dead. Animals 
were euthanized during recovery or upon termination on day 32 
postimmunization. Brain and spinal cords were collected in 10% 
1. Introduction
Multiple sclerosis (MS) is a disease of the central nervous system 
(CNS) characterized by inflammation and infiltration of mononu-
clear cells and the loss of myelin sheath encapsulating the axons 
(Sospedra and Martin, 2005). Autoimmune responses to myelin anti-
gens have been implicated in MS pathogenesis and this requires the 
mediation of autoreactive T cells and B cells, but the mechanisms by 
which the disease is initiated are unknown (Kerlero de Rosbo et al., 
1993; Sospedra and Martin, 2005). Although genetic susceptibility 
is a major predisposing factor, exposure to environmental microbes 
such as viruses and bacteria have been suspected in the initiation of 
autoimmune diseases. Several mechanisms have been postulated to 
explain this phenomenon. These include the release of self-antigens 
or cryptic or new antigenic determinants in the target organs leading 
to the generation of pathogenic CD4 T cells (Miller et al., 1997), by-
stander activationofautoaggressive T cells by superantigens (Brocke 
et al., 1993), and molecular mimicry in which structural homologies 
between self and foreign antigens facilitate the recognition of self tis-
sues by cross-reactivity (Wucherpfennig and Strominger, 1995).
Molecular mimicry is a natural phenomenon and several examples 
exist to provide a proof of concept that the microbial mimics can 
break self-tolerance and induce autoimmune responses in various 
animal studies, including experimental autoimmune encephalo-
myelitis (EAE), the disease model for MS in humans (Fujinami et 
al., 2006; Gautam et al., 1998; Mokhtarian et al., 1999). EAE can be 
induced by active immunization with emulsions containing myelin 
antigens in complete Freund's adjuvant (CFA) or by adoptively 
transferring myelin antigen (Ag)-specific T cells into the susceptible 
animals (Tuohy et al., 1989; Whitham et al., 1991). Three major my-
elin antigens or their peptides have been found to induce EAE in 
rodent or non-rodent species. These are myelin basic protein (MBP) 
(Zamvil et al., 1986), myelin oligodendrocyte glycoprotein (MOG) 
(Mendel et al., 1995), and proteolipid protein (PLP) (Tuohy et al., 
1989). The microbial mimics capable of inducing EAE have been 
reported for all the above except for PLP. These include Herpes vi-
rus saimiri (Gautam et al., 1998), Hepatitis B virus (Fujinami and 
Oldstone, 1985), JC virus (Mao et al., 2007), Chlamydia pneumoniae 
(Conant and Swanborg, 2003), Papilloma virus (MBP mimics) (Ruiz 
et al., 1999), and Semliki forest virus (MOG mimic) (Mokhtarian et 
al., 1999).
Our studies involve PLP 139-151-induced EAE in SJL mice, which 
develop chronic relapsing–remitting paralysis. We sought to iden-
tify the disease-producing microbial mimics for PLP 139-151 from 
pathogens capable of inducing CNS disease and searched for ho-
mologous sequences between PLP 139-151 and pathogens in pro-
Published in the Journal of Neuroimmunology (2010) 219: 17-24. DOI: 10.1016/j.jneuroim.2009.11.006. Copyright 2010, Elsevier. Used by permission.
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Abstract
We report here that an epitope (aa, 83-95) derived from Acanthamoeba castellanii (ACA) induces clinical signs of experimental autoimmune 
encephalomyelitis (EAE) in SJL/J mice reminiscent of the disease induced with myelin proteolipid protein (PLP) 139-151. By using IAs/tetram-
ers, we demonstrate that both ACA 83-95 and PLP 139-151 generate antigen-specific cross-reactive CD4 T cells and the T cells secrete identical 
patterns of cytokines and induce EAE with a similar severity. These results may provide insights into the pathogenesis of multiple sclerosis and 
ACA-induced granulomatous encephalitis.
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fecting SF9 insect cells using a high-titer virus supernatant and the 
tetramers were derived as described previously (Reddy et al., 2003). 
To determine the frequency of Ag-specific T cells, LNC obtained 
from the mice immunized with PLP 139-151 or ACA 83-95 were re-
stimulated with the corresponding peptides (20 µg/ml) for four to 
six days. Viable lymphoblasts were harvested by Ficoll–Hypaque 
density gradient centrifugation and incubated with phycoerythrin 
(PE) conjugated IAs tetramers (30 µg/ml) at room temperature (RT) 
for 3 h followed by staining with anti-CD4 and 7-amino-actinomy-
cin-D (7-AAD) (Eugene, Oregon) (Reddy et al., 2003, 2004). The fre-
quency of tetramer+ (tet+) cells was then enumerated by four-color 
flow cytometric analysis (FACS caliber, BD Pharmingen, San Diego, 
California) and Flow Jo software (Tree star, Ashland, Oregon) in a 
live (7-AAD-) CD4+ population. To determine the Ag specificity of 
cross-reactive T cell responses induced with PLP 139-151 and ACA 
83-95, double tetramer staining was performed using allophycocya-
nin (APC)-conjugated PLP 139-151-and ACA 83-95-PE tetramers.
2.8. Intracellular cytokine staining
LNC from PLP 139-151 or ACA 83-95-immunized groups were re-
stimulated with the respective peptides and maintained in medium 
containing IL-2. Viable lymphoblasts were harvested on day four by 
Ficoll–Hypaque density gradient centrifugation and stimulated for 
4.5 h with Phorbol 12-myristate 13-acetate (PMA) (10 ng/ml) and 
Ionomycin (150 ng/ml) in the presence of 2 mM monensin (Golgi 
stop, BD Pharmingen). After staining with anti-CD4 and 7-AAD, 
cells were fixed, permeabilized and stained with cytokine antibod-
ies or isotype controls (eBioscience, San Diego, California). The fre-
quency of cytokine-secreting cells was then determined in the live 
(7-AAD-) CD4+ subset by flow cytometry (FACS Scan, BD Pharmin-
gen) and analyzed by Flow Jo software (Tree star) (Reddy et al., 
2004). The clones of cytokine antibodies used were: IL-2 (JES6-5H4), 
IL-4 (11B11), IL-10 (JES5-16E3), interferon (INF)-γ (XMG1.2), tumor 
necrosis factor (TNF)-α (MP6XT22), IL-17A (eBio 17B7), IL-17F (eBio 
18F10) (all from eBioscience) and IL-22 (140301) (R&D Systems, Min-
neapolis, Minnesota).
2.9. Cytokine ELISA
Supernatants harvested from the above cultures on day two were 
analyzed for cytokines by ELISA (Nicholson et al., 1995; Reddy et al., 
2004). The clones of the capture and detection antibody (Ab) pairs 
used were: IL-2 (JES6-1A12/JES6-5H4), IL-4 (11B11/BVD6-24G2), 
IL-10 (JES5-16E3/JES5-2A5), IL-17A (eBio17CK15A5/eBio17B7), 
INF-γ (AN-18/R4-6A2), and TNF-α (TN3-19.12/rabbit polyclonal) 
(eBioscience).
2.10. Statistics
Student's t-test was used to determine differences in T cell prolif-
erative responses, tetramer staining, and cytokine secretion between 
groups. Comparisons of histological disease between groups for in-
flammatory lesions in the brain and spinal cords were analyzed by 
two-sided Wilcoxon rank sum test (Mann–Whitney U test). P ≤ 0.05 
values were considered significant.
3. Results
3.1. An epitope derived from A. castellanii induces autoimmune en-
cephalomyelitis
Protein database searches resulted in the identification of seven-
teen sequences derived from organisms that are known to be asso-
ciated with CNS infections in humans with a percent homology of 
38.4 to 53.8 with PLP 139-151 (Table 1). To determine whether or not 
the microbial mimics that bear homologous sequences with PLP 139-
151 induce CNS autoimmunity, we chose ACA 83-95, Bacillus ce-
reus (BCE) 204-216 and MTB 64-76 based on two criteria: (a) Peptides 
should possess a maximum sequence homology with PLP 139-151 
and (b) the homologous sequences should include all of the critical 
TCR and MHC Contact residues (Table 1 and Figure 1). Among the 
three peptides tested, only ACA 83-95 induced the clinical signs of
phosphate buffered formalin and analyzed for histological evidence 
of the disease (Sobel et al., 1990). After fixation, two brain sections 
were made one included cerebrum, and hippocampus, the second 
included cerebellum, and brainstem. In the spinal cord, three sec-
tions were made from each segment (cervical, thoracic, lumbar, and 
sacral). All the tissues were stained by Hematoxylin and Eosin stain-
ing. Tissues were blinded to treatment and lesion type characterized 
and severity scored. Severity scores were obtained by counting in-
flammatory foci in both meninges and parenchyma for all sites. In-
flammation was primarily classified as lymphocytic, suppurative or 
mixed. For statistical analysis counts were added across all sections 
of brain and spinal cord for each mouse.
2.5. Induction of EAE by adoptive transfer
Short-term T cell lines were generated from the mice immunized 
with 100 µg of each PLP 139-151 or ACA 83-95 per mouse. Lymph 
node cells (LNC) obtained from the draining lymph nodes were 
stimulated with the corresponding peptides (20 µg/ml) and rested 
for 14 days in interleukin (IL)-2 medium. Antigen-specific T cells 
were enriched by restimulating with PLP 139-151 or ACA 83-95 (20 
µg/ml) in the presence of syngeneic Ag-presenting cells for two 
days and maintained in IL-2 medium for additional two days. Viable 
lymphoblasts were harvested by Ficoll–Hypaque density gradient 
centrifugation, and groups of naive SJL mice were injected in the tail 
vein with 8.5×106 cells per mouse (Whitham et al., 1991).
2.6. Proliferation Assay
Single cell suspensions were prepared from the draining lymph 
nodes harvested from groups of mice immunized with PLP 139-151 
or ACA 83-95. LNC were stimulated with PLP 139-151, ACA 83-95 
and NASE 101-120 (0–100 µg/ml) at a cell density of 5 to 7.5×106 
cells/ml for two days in RPMI medium supplemented with 10% fe-
tal calf serum, 1 mM sodium pyruvate, 4 mM L-glutamine, 1× each 
of non-essential amino acids and vitamin mixture and 100 U/ml 
penicillin–streptomycin (Lonza, Walkersville, Maryland). Cultures 
were then pulsed with 1 µCi of tritiated 3[H] thymidine per well and 
16 h later, proliferative responses were measured as counts per min-
ute (cpm) using Wallac liquid scintillation counter (Perkin Elmer, 
Waltham, Massachusetts).
2.7. Derivation of MHC class II/IAs tetramers and flow cytometric 
analysis of antigen-specific T cells by tetramer staining
PLP 139-151 and Theiler's murine encephalomyelitis virus (TMEV) 
70-86 tetramers were generated as described (Reddy et al., 2003). 
To derive ACA 83-95 tetramers, IAs construct (gift from Dr. Vijay 
Kuchroo, Harvard Medical School, Boston, Massachusetts) was mod-
ified by excising PLP 139151 sequence using Kpn I and BamH I and 
replaced with the nt sequence encoding ACA 83-95 (5'-TATTTTCT-
TCTTAAATGGCTTGGTCATCCTAATGTTTCT-3'). The soluble IAs 
molecules were expressed in Baculovirus expression system by in-
Figure 1. Comparison of microbial peptide sequences with PLP 139-151. The 
peptide sequences of Acanthamoeba castellanii (ACA), Haemophilus influenzae 
(HAE), Bacillus cereus (BCE), and Mycobacterium tuberculosis (MTB) are com-
pared with proteolipid protein (PLP) 139-151. Homologous sequences are 
underlined.
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group. Importantly, LNC obtained from PLP 139-151-immunized 
group also reacted to ACA 83-95 albeit at a lower level as com-
pared with the native peptide (PLP 139-151) (Figure 4a). Like-
wise, LNC from ACA 83-95-immunized mice also reacted to PLP 
139-151, but the response was low (Figure 4b). Marginally, the 
magnitude of T cell response to PLP 139-151 in ACA 83-95-im-
munized mice was lower than the reactivity to ACA 83-95 in PLP 
139-151-immunized mice.
3.4. Cross-reactive T cell responses induced with ACA 83-95 and 
PLP 139-151 are antigen-specific
To determine if the expansion of T cells that occurred in ACA 
8395-immunized mice react specifically with PLP 139-151, we used 
IAs tetramers for PLP 139-151. Flow cytometric analysis of tet+ cells 
indicated that about 2% of the CD4 cells in PLP 139-151– and 1% in 
ACA 83-95-immunized mice stained with PLP 139-151 tetramers im-
plying that ACA 83-95 generates PLP 139-151-specific T cells (Figure 
5a). To verify the variations, if any, in the generation of precursor 
frequency of PLP 139-151-specific T cells in mice immunized with 
PLP 139-151 and ACA 83-95, we developed tetramers for ACA 83-95. 
Consistent with the proliferative responses, PLP 139-151 tet+ cells in 
PLP 139-151-immunized mice and ACA 83-95 tet+ cells in ACA 83-95 
immunized mice were evident as predicted (Figure 5b). The  stain-
EAE by active immunization. There were no clinical signs of EAE 
in the mice immunized with BCE and MTB peptides, nor was there 
consistent evidence of inflammation on histological evaluation of 
CNS tissues (data not shown).
Comparison of disease severity and patterns of clinical EAE in-
duced with PLP 139-151 and ACA 83-95 revealed a few noteworthy 
observations (Figure 2a and Table 2). First, the onset of EAE induc-
tion was similar for both PLP 139-151 and ACA 83-95 peptides (~day 
11) and among the clinically affected mice, the mean maximum neu-
rological scores were marginally higher for PLP 139-151 when com-
pared with mice immunized with ACA 83-95 (3.39 vs. 2.20) (Table 
2). Second, EAE occurred in all of the mice immunized with PLP 
139-151 and 72.7% (16/22) of the mice immunized with ACA 83-95 
showed signs of EAE clinically and/or histologically. Of these, 45% 
(10/22) of mice showed both clinical and histological EAE (Figure 
2aand Table 2) and the remaining six mice (27.3%) while showing 
no clinical signs of EAE had histological evidence of disease. Third, 
consistent with the clinical EAE, histologically, the severity of the 
disease was significantly milder in mice immunized with ACA 83-95 
than in mice immunized with PLP 139-151 as revealed by fewer foci 
of inflammation in the brain and spinal cords (p = 1.6624 E-23) (Table 
2 and Figure 3i). When evident, regardless of clinical EAE or not, 
infiltrates in both PLP 139-151-and ACA 83-95-immunized groups 
primarilycomprisedperivascular cuffing of lymphocytes with few 
histiocytes and plasma cells of the brain and spinal cords as the dis-
ease severity increased. Mixed as reported previously (Sobel et al., 
1990). Inflammation was limited to infiltrates made of both neutro-
phils and MNC were present in most meninges in mice with mild 
EAE, but it was extended into the parenchyma severe lesions.
3.2. ACA 83-95-and PLP 139-151-reactive T cells induce EAE with a 
similar severity
Short-term T cell lines were obtained from SJL mice immunized 
with PLP 139-151 and ACA 83-95 and viable lymphoblasts were ad-
ministered into groups of naïve SJL mice. The T cells reacting with 
each individual peptide induced clinical EAE of similar course, se-
verity and histology beginning at day five posttransfer (Figures 2b 
and 3ii and Table 2). Infiltrations comprised of MNC and neutro-
phils were present in both groups of mice.
3.3. ACA 83-95 induces T cell responses that cross-react with PLP 139-151
To measure recall responses, we used LNC obtained from mice im-
munized with ACA 83-95 or PLP 139-151. As shown in Figure 4, both 
PLP 139-151 and ACA 83-95 induced comparable T cell responses in 
a dose-dependent manner and the response was specific, because 
NASE 101-120 (control peptide) failed to stimulate T cells from either
Table 1
Microbial peptides that mimic CNS myelin PLP 139-151.
Source                 Sequence            Homology(%)
PLP 139-151              HSLGKWLGHPDKF
Acanthamoeba castellanii        YFLLKWLGHPNVS      53.8
Bacillus anthracis str. Ames       VELEKWLRHPSYF      53.8
Bacillus cereus G9241         VELEKWLSHPSYF      53.8
Bacillus cereus NVH0597-99      VKLEKWLSHPSYF      53.8
Chaetomium globosum CBS 148.51   HHLPSWLGHPTRV     53.8
Mycobacterium tuberculosis CDC1551 DSLGEWLRHPYCA     53.8
Mycobacterium avium 104       ESLGEWLRHPYCA      53.8
Mycobacterium avium sub sp. 
   paratuberculosis         ESLGEWLRHPYCA      53.8
Mycobacterium tuberculosis H37Rv   DSLGEWLRHPYCA     53.8
Nostoc punctiforme PCC73102     TDLEVWLGHPGKV     53.8
Nostoc sp. PCC 7120          TDLEVWLGHPGKV     53.8
Borna disease virus          QFLRSWLNHPDII      46.1
Trichinella spiralis           PPLSTWLGHPNHS      46.1
Nematostella vectensisa         CGLCAWLIHPCV      38.4
                   CCLCVWLIHPCNV     38.4
                   CCLCVWLIHPCIVb      38.4
                   CFLCVWLIHPCIV      38.4
Homologous residues are underlined.
aPossesses five peptide sequences that mimic PLP 139-151 as shown.
bExists as duplicate sequence.
Figure 2. Induction of EAE by PLP 139-151 and ACA 83-95. (a) Induction of 
EAE by active immunization. SJL mice were immunized with 100 µg each of 
PLP 139-151 or ACA 83-95 in CFA and pertussis toxin was administered on 
day 0 and 2 postimmunization. The mice were monitored for clinical signs of 
EAE and scored. i–iii Mean values for all the mice in a group regardless of the 
presence or absence of clinical signs of EAE obtained from three individual ex-
periments are indicated. iv Mean values for only the mice that showed clinical 
EAE in all of the above three experiments are shown as a pool. (b) Induction 
of EAE by adoptive transfer. Short-term T cell lines were derived from mice 
immunized with PLP 139-151 or ACA 83-95 and viable lymphoblasts were 
injected into naive SJL mice intravenously, and the mice were monitored for 
signs of EAE and scored. Mean values for a group of mice are shown.
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stimulated with the immunizing peptides. That is, cultures derived 
from mice immunized with PLP 139-151 showed positive staining 
for ACA 83-95 tetramers and vice versa (Figure 5b). However their 
ing was specific since there was negligible binding to control tetram-
ers (TMEV 70-86). Importantly, tetramer analysis also revealed posi-
tive staining for unimmunized cross-reacting peptides in cultures 
Table 2
Clinical and histologic EAE in SJL mice induced with PLP 139-151 and ACA 83-95.a
Treatment   Clinical disease       No. of inflammatory foci
  Incidence (%)  Mean day of onsetc  Mean maximum scorec  Meninges   Parenchyma              Total
Active immunization
PLP 139-151  18/18 (100)  11.18±0.44   3.39±0.28    45.44±8.88   40.00±9.63                  85.44±17.84
ACA 83-95b  10/22 (45)   11.70±1.21   2.20±0.29    5.59±1.57   3.77±0.9                  9.36±2.15
p values      0.011418    2.3416E-23   1.30E-10                  1.6624E-23
Adoptive transfer
PLP 139-151  6/6 (100)   6.83±1.01   4.50±0.34    182.17±19.39  122.17±27.45              304.33±46.56
ACA 83-95  6/6 (100)   7.83±1.33   4.67±0.33    136.83±13.65  100.67±16.94              237.50±30.55
Scoring scale: 0, healthy; 1, limp tail or hind limb weakness but not both; 2, limp tail and hind limb weakness; 3, partial paralysis of hind limbs; 4, complete paralysis 
of hind limbs; and 5, moribund or dead.
aNumbers are mean±SEM.
bIn this group, tissues from one mouse were retained for another aspect of the study.
cRepresents only mice that showed clinical disease.
Figure 3. Histological evaluation of EAE induced with PLP 139-151 and ACA 83-95. (i) EAE induced by active immunization. Brain (a) and spinal cord (b) of PLP 
139-151-immunized mouse with extensive perivascular lymphocytic infiltration (arrows) as compared with mild lymphocytic perivascular cuffing (arrow) in brain 
(c) and spinal cord (d) of ACA 83-95-immunized mouse. (ii) Similar lymphocytic mixed perivascular cuffing (arrows) in the brain and spinal cord of mice that re-
ceived PLP 139-151 (a and b) and ACA 83-95 (c and d) -specific T cells. Original magnification, ×400 (bar = 20 µm).
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sequences can act as natural altered peptide ligands and prevent au-
toimmune responses. For example, a peptide from human papilloma 
virus and Bacillus subtilis generate T cell responses that cross-react 
with MBP 87–99, but they prevent the induction of EAE (Ruiz et 
al., 1999). These observations suggest that microbial exposure does 
not necessarily mean that detrimental organ-specific autoimmune 
responses ensue. Nonetheless, identifying peptides from microbes 
that are known to cause CNS illness provides opportunities to inves-
tigate their potential involvement in the initiation of autoimmune 
diseases. We chose ACA 83-95, BCE 204-216 and MTB 64-76 to test 
their disease-inducing potential and of these, only ACA 83-95 in-
duced the clinical signs of EAE by active immunization. It has been 
previously reported that HAE 574-586 was found to generate T cell 
responses that cross-react with PLP 139-151, but was unable to in-
duce EAE by active immunization except in mice primed with sub-
optimal doses of PLP 139-151 (Carrizosa et al., 1998) or in mice in 
which a preexisting population of HAE 574-586–specific T cells was 
created by viral delivery (Croxford et al., 2005). ACA 83-95 differs 
from HAE 574-586 in that it possesses histidine at position 147 as an 
additional residue. The fact that ACA peptide, but not HAE peptide, 
induces EAE suggests that the presence of both primary (tryptophan, 
position 144) and secondary contact residues (leucine, position 141; 
and histidine, position 147) are essential to induce encephalitogenic 
T cell responses (Figure 1). This may be why HAE 574–586 by itself 
failed to induce EAE. In the case of two other peptides, namely BCE 
204-216 and MTB 6476, the secondary contact residue was present, 
but failed to induce EAE or generated cross-reactive T cell responses, 
and they were poorly immunogenic (data not shown). It may be that 
they bind weakly to MHC and/or TCR or that some of the non-crit-
ical TCR and MHC residues in the non-immunogenic peptides may 
be essential for maintaining the conformation of the epitope for effi-
cient TCR and MHC recognition as previously speculated (Croxford 
et al., 2005).
Comparison of the incidence and EAE severity induced by PLP 
139151 with that of ACA 83-95 revealed that ACA 83-95 induced 
clinical and/or histological EAE in only 72.7% of animals and the 
disease severity was mild (Figure 2 and Table 2). Lack of 100% in-
cidence and the less severe nature of EAE induced with ACA 83-95 
suggest three possibilities: (a) ACA 83-95-induced cross-reactive T 
cell responses with PLP 139-151 are less encephalitogenic than those 
that can be obtained from immunization with native PLP 139-151 
peptide. (b) The generation of the precursor frequency of cross-reac-
tive T cells induced with ACA 8395 immunization might be low and 
(c) the functional phenotype of ACA 83-95-induced T cell population 
might be different with respect to the production of inflammatory 
cytokines. We tested whether the T cells generated in response to 
ACA 83-95 can induce EAE in adoptive transfer experiments. Both 
the T cells that react with PLP 139-151 and ACA 83-95 induced the 
clinical signs of EAE in a similar manner clinically (Figure 2b) and 
histologically (Table 2 and Figure 3ii) indicating that ACA 83-95 can 
generate potent autoaggressive T cells and induce EAE. Reports in-
dicate that the naturally occurring Acanthamoeba granulomatous 
encephalitis (AGE) induced with ACA accompanies infiltrations 
consisting of MNC, plasma cells, and multinucleated giant cells 
(Marciano-Cabral and Cabral, 2003). In our studies with ACA 83-95, 
although MNC were present, the dominance of plasma cells and gi-
ant cells was absent. This lack of similarity is not surprising, because 
the pathology that occurs in AGE is due to the presence of infectious 
organism in the brain which may involve the mediation of multiple 
factors and different cell types.
Since both PLP 139-151- and ACA 83-95-reactive T cells induced 
EAE with a similar severity; we asked if the differences in disease 
severity induced by active immunization are due to variations in 
the generation of precursor frequency of Ag-specific T cells. Figure 4 
shows that both PLP 139-151 and ACA 83-95 induce T cell responses 
for both immunizing and unimmunizing peptides in a criss-cross 
manner. Importantly, the reactivity to PLP 139-151 in ACA 83-95-im-
munized mice was marginally low, which raised the question of 
whether the generation of the precursor frequency of the disease-in-
frequency is less than that observed with the immunizing peptides. 
We further verified the Ag specificity of cross-reactive T cells for 
PLP 139-151 and ACA 83-95 in the mice immunized with the corre-
sponding peptides by double tetramer staining using the tetramers 
conjugated with two different dyes namely APC and PE. Figure 5c 
shows a fraction of CD4 T cells generated in response to PLP 139-151 
or ACA 83-95 stained with both PLP 139-151 and ACA 83-95 tetram-
ers, proving further that their T cells cross-react with each peptide. 
Notably, while the majority of ACA 83-95-reactive T cells that are 
generated in response to PLP 139151 immunization also stained with 
PLP 139-151 tetramers, only about a third of the ACA 83-95-reactive 
T cells generated in response to ACA 83-95-immunization stained 
with PLP 139-151 tetramers (Figure 5c).
3.5. Both ACA 83-95 and PLP 139-151 induce similar cytokine pro-
files
Cytokine secretion was tested by intracellular staining to enumer-
ate the frequency of cytokine-secreting cells and in culture superna-
tants by ELISA (Figure 6). The cytokine panel consisted of T helper 
(Th) 1 (IL-2 and IFN-.), Th2 (IL-4 and IL-10), Th17 (IL-17A, IL-17F 
and IL22), and TNF-a. By analyzing the frequency of cytokine-se-
creting cells in the live CD4 T cell population, it was evident that the 
cells capable of secreting all of the cytokines tested were present in 
cultures stimulated with PLP 139-151 and ACA 83-95 and that the 
difference between the two groups was not significant (Figure 6a). 
While both PLP 139-151 and ACA 83-95 induced predominantly Th1 
and Th17 cytokine production, the frequency of the combined cy-
tokinesecreting CD4 T cells with respect to Th1, but not Th17 subset 
tended to be lower in ACA 83-95-than in PLP 139-151-stimulated 
cultures (ACA 83-95: Th1, 16.40±3.83% and Th17, 12.87±3.18%; PLP 
139151: Th1, 22.27±5.38% and Th17, 13.66±1.89%) (n = 4). Similar 
trends were noted when cytokine secretion was evaluated by ELISA 
(Figure 6b) with no significant differences between the mice immu-
nized with PLP 139-151 and ACA 83-95.
4. Discussion
We have identified a peptide mimic from the protozoan parasite, 
A. castellanii that induces clinical signs of EAE by generating cross-
reactive T cell responses with CNS myelin PLP 139-151. Microbial 
peptides that mimic myelin antigens capable of inducing CNS auto-
immunity have been described and many of these are derived from 
pathogens that can cause CNS diseases in humans implying that they 
may have a role in the pathogenesis of autoimmune encephalomyeli-
tis. It is also true that the microbial mimics generate cross-reacting T 
cell responses, but are unable to induce EAE as in the case of Haemo-
philus influenzae (HAE), 574–586 bearing homologous residues with 
PLP 139-151 (Carrizosa et al., 1998). Furthermore, microbial mimic
Figure 4. PLP 139-151 and ACA 83-95 induce cross-reactive T cell responses. 
Groups of SJL mice were immunized with PLP 139-151 or ACA 83-95 and 
after 10 days, mice were euthanized and lymph nodes were harvested. Lymph 
node cells were stimulated with PLP 139-151, ACA 83-95 and NASE 101-120 
(control) for two days. Cells were then pulsed with tritiated 3[H] thymidine, 
the incorporation of which was measured as cpm 16h later. Mean±SEM values 
for a group of mice are shown (n = 4).
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mice could explain the lack of 100% disease incidence in the mice 
immunized with ACA 83-95. This is likely because the mice that re-
ceived PLP 139151- and ACA 83-95-specific T cells developed EAE 
with a similar disease phenotype, both clinically and histologically 
(Figures 2b and 3ii and Table 2).
To determine whether differences in the severity of EAE induced 
with ACA 83-95 and PLP 139-151 might be due to variations in the 
production of cytokines, we evaluated cytokine secretion in LNC 
obtained from PLP 139-151-and ACA 83-95-immunized mice, but it 
was not the case (Figure 6). It has been recently suggested that the 
production of Th17 cytokines marks the generation of potent auto-
aggressive T cell populations (McGeachy and Cua, 2008) and we did 
not see such a skewed response to either of the two peptides. It is 
likely that the T cells capable of producing both Th1 and Th17 cy-
tokines may have contributed to the disease phenotypes. Although 
both Th1 and Th17 cells could contribute to EAE pathogenicity, it 
appears that the ratio between the two subsets of T cells determines 
the severity of EAE in that predominance of Th17 over Th1 cells 
exacerbates inflammation and infiltration into the CNS (Bettelli et 
al., 2007; Stromnes et al., 2008). Furthermore, it has been proposed 
that Th1 cells enter non-inflamed CNS tissues prior to Th17 cells and 
initiate inflammation and that they facilitate the entry of Th17 cells 
(O'Connor et al., 2008). We have observed that ACA 83-95 induced 
a relatively lesser proportion of Th1 cells when compared with PLP 
139151 (16.40 vs. 22.27%) and this difference in the generation of 
Th1 cells might have contributed to the less severe nature of EAE 
induced with ACA 83-95.
Genetic susceptibility and environmental factors predispose to the 
development of autoimmune responses. It is possible that exposure 
to pathogens that bear homologous sequences with self-antigens 
ducing PLP 139-151-specific T cells is low in ACA 83-95-immunized 
mice. We confirmed these differences in the expansion of Ag-specific 
T cells by tetramer staining (Figure 5). The lesser magnitude in the 
generation of PLP 139-151-specific T cells in ACA 83-95-immunized 
Figure 5. Cross-reactive T cell responses induced by PLP 139-151 and ACA 83-95 are Ag-specific. (a) IAs/PLP 139-151 tetramers detect PLP 139-151-reactive T cells 
in mice immunized with ACA 83-95. LNC obtained from SJL mice immunized with PLP 139-151 or ACA 83-95 were restimulated with the corresponding peptides 
and tetramer staining was performed flow cytometrically by using PE-conjugated PLP 139-151 and TMEV 70–86 tetramers, anti-CD4 and 7-AAD as described in 
Materials and methods section. Percentages of tet+CD4+ T cells were enumerated in live (7-AAD-) populations. Mean±SEM values are shown (n = 3 per group). 
(b) Cross-reactive T cells induced by PLP 139-151 and ACA 83-95 are Ag-specific. IAs tetramers involving PLP 139-151, ACA 83-95 and TMEV 70–86-PE were used 
to stain LNC stimulated with PLP 139-151 or ACA 83-95 and analyzed by flow cytometry. Tet+ cells in CD4 subset are shown. (c) Detection of cross-reactive T cell 
responses by double tetramer staining. APC-conjugated PLP 139-151 and PE-conjugated ACA 83-95 tetramers were used to stain LNC stimulated with PLP 139-151 
or ACA 83-95 and the tet+ cells are shown in CD4 subset. In all of the staining reactions, TMEV 70–86 tetramers were included as negative controls and 7-AAD as 
a cell death marker.
Figure 6. PLP 139-151 and ACA 83-95 induce identical cytokine patterns. (a) 
Cytokine detection by intracellular staining. Lymph node cells derived from 
SJL mice immunized with PLP 139-151 or ACA 83-95 were stimulated with the 
corresponding peptides for two days and the cultures were maintained in IL-2 
medium for additional two days. Viable lymphoblasts were harvested and 
stimulated with PMA and ionomycin for 4.5 h in the presence of monensin 
and stained with anti-CD4 and 7-AAD. After fixation and permeabilization, 
the cells were incubated with cytokine antibodies and the frequency of cy-
tokine+ cells was enumerated by flow cytometry in the live (7-AAD-) CD4+ 
T cells. Percentages of cytokine-secreting CD4 T cells for a group of mice are 
shown (n = 4). (b) Cytokine detection by ELISA. Supernatants harvested on 
day two poststimulation with peptides from the above cultures were analyzed 
for cytokines by ELISA. Each bar represents mean ± values for a group of mice 
(n = 4).
A. castellanii Epitope That Cross-React with Proteolipid Protein 139-151-Reactive T Cells Induces Autoimmune Encephalomyelitis in SJL Mice  23
Claerhout, I., Kestelyn, P., 1999. Acanthamoeba keratitis: a review. 
Bull. Soc. Belge Ophtalmol. 274, 71–82. Conant, S.B., Swanborg, 
R.H., 2003. MHC class II peptide flanking residues of exogenous 
antigens influence recognition by autoreactive T cells. Autoimmun. 
Rev. 2: 8–12.
Croxford, J.L., Anger, H.A., Miller, S.D., 2005. Viral delivery of an 
epitope from Haemophilus influenzae induces central nervous sys-
tem autoimmune disease by molecular mimicry. J. Immunol. 174: 
907–917.
Ercolini, A.M., Miller, S.D., 2005. Role of immunologic cross-reactiv-
ity in neurological diseases. Neurol. Res. 27: 726–733.
Fujinami, R.S., Oldstone, M.B., 1985. Amino acid homology between 
the encephalitogenic site of myelin basic protein and virus: mecha-
nism for autoimmunity. Science 230: 1,043–1,045.
Fujinami, R.S., von Herrath, M.G., Christen, U., Whitton, J.L., 2006. 
Molecular mimicry, bystander activation, or viral persistence: in-
fections and autoimmune disease. Clin. Microbiol. Rev. 19: 80–94.
Gautam, A.M., Liblau, R., Chelvanayagam, G., Steinman, L., Boston, 
T., 1998. A viral peptide with limited homology to a self peptide 
can induce clinical signs of experimental autoimmune encephalo-
myelitis. J. Immunol. 161: 60–64.
Kerlerode Rosbo, N., Milo, R., Lees, M.B., Burger, D., Bernard, 
C.C., Ben-Nun, A., 1993. Reactivity to myelin antigens in multiple 
sclerosis. Peripheral blood lymphocytes respond predominantly 
to myelin oligodendrocyte glycoprotein. J. Clin. Invest. 92: 2,602–
2,608.
Klein, L., Klugmann, M., Nave, K.A., Tuohy, V.K., Kyewski, B., 
2000. Shaping of the autoreactive T-cell repertoire by a splice vari-
ant of self protein expressed in thymic epithelial cells. Nat. Med. 
6: 56–61.
Mao, Y.S., Lu, C.Z., Wang, X., Xiao, B.G., 2007. Inductionofexperi-
mental autoimmune encephalomyelitis in Lewis rats by a viral 
peptide with limited homology to myelin basic protein. Exp. Neu-
rol. 206: 231–239.
Marciano-Cabral, F., Cabral, G., 2003. Acanthamoeba spp. as agents of 
disease in humans. Clin. Microbiol. Rev. 16: 273–307.
Marciano-Cabral, F., Ludwick, C., Puffenbarger, R.A., Cabral, G.A., 
2004. Differential stimulation of microglial pro-inflammatory cy-
tokines by Acanthamoeba culbertsoni versus Acanthamoeba castellanii. 
J. Eukaryot. Microbiol. 51: 472–479.
McGeachy, M.J., Cua, D.J., 2008. Th17 cell differentiation: the long 
and winding road. Immunity 28: 445–453.
Mendel, I., Kerlero de Rosbo, N., Ben-Nun, A., 1995. A myelin oli-
godendrocyte glycoprotein peptide induces typical chronic experi-
mental autoimmune encephalomyelitis in H-2b mice: fine specific-
ity and T cell receptor V beta expression of encephalitogenic T cells. 
Eur. J. Immunol. 25: 1,951–1,959.
Miller, S.D., Vanderlugt, C.L., Begolka, W.S., Pao, W., Yauch, R.L., 
Neville, K.L., Katz-Levy, Y., Carrizosa, A., Kim, B.S., 1997. Persis-
tent infection with Theiler's virus leads to CNS autoimmunity via 
epitope spreading. Nat. Med. 3: 1,133–1,136.
Mokhtarian, F., Zhang, Z., Shi, Y., Gonzales, E., Sobel, R.A., 1999. 
Molecular mimicry between a viral peptide and a myelin oligoden-
drocyte glycoprotein peptide induces autoimmune demyelinating 
disease in mice. J. Neuroimmunol. 95: 43–54.
Nicholson, L.B., Greer, J.M., Sobel, R.A., Lees, M.B., Kuchroo, V.K., 
1995. An altered peptide ligand mediates immune deviation and 
prevents autoimmune encephalomyelitis. Immunity 3: 397–405.
O'Connor, R.A., Prendergast, C.T., Sabatos, C.A., Lau, C.W., Leech, 
M.D., Wraith, D.C., Anderton, S.M., 2008. Cutting edge: Th1 cells 
facilitate the entry of Th17 cells to the central nervous system dur-
ing experimental autoimmune encephalomyelitis. J. Immunol. 181: 
3,750–3,754.
Pette, M., Fujita, K., Wilkinson, D., Altmann, D.M., Trowsdale, J., 
Giegerich, G., Hinkkanen, A., Epplen, J.T., Kappos, L., Wekerle, 
H., 1990. Myelin autoreactivity in multiple sclerosis: recognition of 
myelin basic protein in the context of HLA-DR2 products by T lym-
phocytes of multiple-sclerosis patients and healthy donors. Proc. 
Natl. Acad. Sci. U.S.A. 87: 7,968–7,972.
could lead to the generation of cross-reactive T cells both in periph-
ery and locally within the CNS. Myelin antigens such as MBP and 
PLP can be expressed in thymus and peripheral lymphoid tissues 
and aberrant expression of PLP transcripts importantly DM20, an 
isoform of PLP lacking PLP 139-151 motif contribute to the endog-
enous generation of PLP 139-151 reactive T cells by escaping central 
tolerance (Anderson et al., 2000; Klein et al., 2000; Voskuhl, 1998). 
Furthermore, healthy humans including MS patients react to MBP 
or PLP suggestive of the existence of endogenous myelin reactive 
T cell repertoires and the resident dendritic cells and microglia can 
present antigens locally within CNS (Bailey et al., 2007; Pette et al., 
1990; Wucherpfennig and Strominger, 1995). Therefore, it is likely 
that during the course of natural infection with ACA, the resident 
Ag-presenting cells can present a peptide encompassing 83-95, stim-
ulate the expansion of PLP 139-151-reactive CD4 T cells by molecu-
lar mimicry, and induce autoimmunity in the CNS.
In summary, we have provided evidence that ACA 83-95 derived 
from a protozoan parasite can induce CNS autoimmunity by mo-
lecular mimicry. ACA is a free-living organism present throughout 
the world habituating in water, soil, and dust, and it causes AGE, 
amoebic keratitis and cutaneous amoebiasis in infected humans 
(Claerhout and Kestelyn, 1999; Marciano-Cabral and Cabral, 2003). 
AGE is a chronic progressive disease of the CNS commonly seen 
in chronically ill, debilitated, or immunocompromised individu-
als such as AIDS patients (Marciano-Cabral and Cabral, 2003). The 
amoebae activate phosphatidylinositol 3-kinase to induce apoptosis 
of brain microvascular endothelial cells and successfully traverse 
the blood–brain barrier to induce AGE (Sissons et al., 2005). IL-1ß 
has been implicated in the formation of granuloma in the CNS tis-
sues, but it is unclear whether the hemorrhagic necrosis caused by 
Acanthamoeba infections results from destruction of brain tissue or 
inflammatory cytokines (Marciano-Cabral et al., 2004). Presently, it 
is not known if natural infection with ACA trophozoites can lead 
to the generation of PLP-reactive T cells or T cell clones specific to 
other myelin antigens, which could be released as a consequence of 
epitope spreading (Miller et al., 1997). Molecular mimicry has been 
proposed as one of the phenomena for the occurrence of a number 
of autoimmune diseases (Ercolini and Miller, 2005). Although not 
known presently, our data provide a rationale to test whether there 
is any possible association of ACA infection with the occurrence of 
autoimmune encephalomyelitis. It may be possible that in genetical-
ly susceptible individuals who are immunocompromised, exposure 
to ACA can trigger CNS autoimmunity by molecular mimicry.
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